U.S. Life Sciences Stock News

Hawaiian Electric Industries reported full-year 2025 revenue of US$3.09 billion, down slightly from US$3.22 billion in 2024, while swinging from a very large net loss to net income of US$123.12 million, or US$0.71 in basic and diluted earnings per share from continuing operations. The earnings rebound coincided with progress on Maui wildfire-related settlements, funded by insurance, and regulatory approval of a multi-year wildfire safety plan that supports both risk reduction and grid...

If you are wondering whether Enpro's current share price really reflects its underlying worth, this article walks through what the numbers actually say about value. Enpro's share price recently closed at US$264.05, with returns of 10.6% over 30 days, 20.5% year to date, 49.2% over 1 year, 155.4% over 3 years and 205.4% over 5 years. These figures may catch the eye of investors thinking about future risk and reward. Recent coverage around Enpro has focused on its role within the capital goods...

Why AES (AES) is on investors’ radar today AES (AES) is drawing attention after a mixed run in its share price, with a 1 day return of around 0.18% and a past 3 months total return of about 1.79%. Over the past year, the stock’s total return of roughly 34.25% contrasts with weaker multi year figures. At the same time, annual revenue of about US$12.1b and net income of roughly US$1.1b frame the current debate around valuation and business momentum. See our latest analysis for AES. That sharp 1...

UFP Technologies (NasdaqCM:UFPT) amended its manufacturing supply agreement with Intuitive Surgical. The amendment extends the term of the partnership between the two companies. Minimum volume commitments under the agreement were increased. A new program for additional products was added to the supply arrangement. For you as an investor, this centers on UFP Technologies' role as a specialized manufacturer for the medical device sector, supplying components and solutions to a leading global...

Earnings, guidance and new buyback put Expro Group Holdings (XPRO) in focus Expro Group Holdings (XPRO) is back on investors’ radar after releasing fourth quarter and full year 2025 results, setting 2026 revenue guidance, and unveiling a new US$100 million share repurchase plan. The latest numbers give you a fresh look at how the business ended 2025. The guidance and buyback outline how management is thinking about the next phase. Here is what stands out from the announcement and how you...

Harrow (NasdaqGM:HROW) has introduced a new Direct-to-Prescriber PharmaPack offering focused on post-cataract surgery care. The PharmaPack kits provide access to FDA-approved ophthalmic products and are designed to be ordered directly by eye care providers. The launch aims to reduce reliance on off-label compounded formulations and support more standardized treatment protocols. For investors following ophthalmic therapeutics, Harrow sits at the intersection of branded eye care drugs and...

If you are wondering whether Truist Financial's current share price really lines up with its underlying worth, this article will walk through the key numbers that matter most. Over the short term, the stock has seen a 1.1% decline over 7 days and a 3.6% decline over 30 days. The longer term picture shows a 14.3% return over 1 year, 26.4% over 3 years, and 5.1% over 5 years from a last close of US$49.55. Recent market attention around large US banks has kept Truist Financial in focus,...

This article examines whether PENN Entertainment at around US$14.85 appears attractively priced or potentially a value trap, by reviewing what the available numbers indicate about the stock. The share price has moved sharply in the short term, with a 22% return over the last 7 days and 15.7% over the last 30 days. This contrasts with a 28.5% decline over 1 year and a 51% decline over 3 years. Recent headlines have focused on PENN Entertainment's position in the US gaming and entertainment...

If you are wondering whether SPS Commerce shares are now priced attractively or still look expensive, you are not alone. This review is aimed squarely at that question. The stock most recently closed at US$58.41, with returns of 7.7% over the past week, a 34.6% decline over 30 days, a 33.6% decline year to date, and a 55.8% decline over 1 year. The 3 year and 5 year returns stand at 61.2% and 41.1% declines respectively. Recent coverage around SPS Commerce has focused on keeping investors...

Veracyte (VCYT) has drawn attention after recent share price moves, with the stock showing mixed returns across different time frames, including declines over the past month and past 3 months alongside a positive 1 year total return. See our latest analysis for Veracyte. At a share price of US$36.01, Veracyte’s recent performance reflects fading short term momentum, with a 30 day share price return of 5.44% and a 90 day share price return of a 21.99% decline, set against a 1 year total...

In late February 2026, Virtu Financial reported Q4 2025 results showing its highest quarterly adjusted net income since early 2021, supported by elevated market volatility and strong trading volumes across both Market Making and Execution Services. An interesting angle for investors is Virtu’s plan to channel this momentum into higher trading capital, upgraded infrastructure, and moves into emerging areas such as prediction markets and crypto. We’ll now explore how this stronger quarter,...

If you are looking at Fluor and wondering whether the current share price gives you good value, you are not alone. This article focuses squarely on what you might be paying for compared to what you are getting. After closing at US$50.91, the stock has seen a 1.4% decline over the last 7 days, a 10.2% gain over 30 days, a 22.1% return year to date, and a 37.9% return over the past year, which may change how investors think about both upside and risk. Recent attention on Fluor has been driven...

Exzeo Group has entered into a new partnership with Tokio Marine Highland to distribute TMH2O residential flood insurance. The collaboration expands Exzeo’s property insurance offerings and supports its ambitions as a multi-line, technology driven platform. For investors tracking NYSE:XZO, this announcement comes as the stock trades at $16.1, with a 3.7% gain over the past week and a 20.8% decline over the past month. Year to date, shares show a 29.3% decline, so this move may stand out as...

If you are wondering whether AutoZone's share price still reflects good value after a long run in the auto parts sector, this article will help you break that question into clear valuation checks. AutoZone shares most recently closed at US$3,882.47, with returns of 1.4% over 7 days, 4.8% over 30 days, 17.5% year to date, 11.6% over 1 year, 54.1% over 3 years and 212.8% over 5 years. This gives plenty of history for investors to consider. Recent news coverage around AutoZone has focused on...

Why Arhaus Stock Is Drawing Attention Now Arhaus (ARHS) has pulled back recently, with the share price down over the past month and past 3 months. This move is prompting investors to reassess how its current valuation lines up with the underlying business. The company reports annual revenue of US$1,379.2m and net income of US$67.3m, and some models suggest the shares trade at a sizeable discount to certain intrinsic value estimates. This can attract interest from value oriented investors. See...

U.S. Gold Corp. recently presented at the Emerging Growth Virtual Conference on February 25, 2026, with Executive Chairman Luke Anthony Norman addressing investors. This appearance gave the company a platform to highlight its latest corporate developments and project plans directly to a broad investment audience. We’ll now explore how U.S. Gold Corp.’s Emerging Growth Virtual Conference presentation could shape its investment narrative and investor expectations. The best AI stocks today may...

WD-40 Company recently expanded its board of directors to 10 members by appointing Ken Plunk, a former J&J Snack Foods chief financial officer and long-time Wal-Mart executive, to serve on its Audit and Finance Committees effective February 18, 2026. This appointment brings extensive financial, international operations, and risk oversight experience to WD-40’s board, potentially strengthening governance around capital allocation, global expansion, and operational efficiency. Next, we’ll...

In February 2026, Glaukos Corporation reported past fourth-quarter and full-year 2025 results showing sales rising to US$143.12 million for the quarter and US$507.44 million for the year, alongside a larger net loss and a US$112,867,000 impairment of intangible assets, and it also issued 2026 net sales guidance of US$600 million to US$620 million. Glaukos has also filed a US$69.25 million shelf registration tied to an ESOP-related common stock offering, highlighting how the company is...

DT Midstream, Inc. reported full-year 2025 results showing sales rising to US$1,243 million and net income to US$441 million, alongside a 7% dividend increase to US$0.88 per share and a US$396.99 million shelf registration for 3,000,000 shares related to its ESOP. Management’s disclosure that its project pipeline is several times larger than the announced US$3.40 billion capital plan, with growth expected to outpace a 7% annualized rate through the rest of the decade, points to a materially...

Viridian Therapeutics (VRDN) is in focus after reporting a larger than expected Q4 2025 loss and lower than forecast revenue. Its lead thyroid eye disease candidate remains under FDA Priority Review and EMA review. See our latest analysis for Viridian Therapeutics. At a share price of US$30.25, Viridian’s 1 day share price return of 2.96% and 7 day share price return of 7.77% follow a weaker 30 day share price return of an 8.33% decline. The 1 year total shareholder return of 109.92%...

Revvity (RVTY) has recently drawn investor attention after a period of weaker share performance, with the stock showing negative returns over the past week, month, past 3 months and year. See our latest analysis for Revvity. With the share price at $95.59 and a 30 day share price return of 12.14% decline, recent weakness builds on a softer trend, as the 1 year total shareholder return of 13.16% decline and 3 year total shareholder return of 25.03% decline point to fading momentum despite...

Recent share performance and business profile Without a specific headline event driving trading activity today, Two Harbors Investment (TWO) has still drawn attention after a recent share price move, prompting investors to reassess its risk and income profile. The stock shows a 1 day return of around a 1% decline, with a 7 day move of about a 3% decline and a one month performance near an 11% decline, while the past 3 months sit modestly positive. Over longer periods, total returns are mixed,...

In February 2026, Stable Sea announced a partnership with dLocal to power low-cost, high-speed stablecoin-based B2B cross-border payments across more than 40 countries, using dLocal’s local payout rails. This collaboration highlights how dLocal is deepening its role in emerging-market payment infrastructure by combining its local rails with stablecoin settlement for large-ticket international transactions. Next, we’ll explore how integrating stablecoin rails into its cross-border platform...

Kadant Inc. recently reported its fourth-quarter and full-year 2025 results, showing quarterly sales of US$286.2 million and flat net income of US$24.03 million, alongside essentially unchanged earnings per share versus the prior year. For 2025 as a whole, Kadant’s sales were broadly stable at about US$1.05 billion, but full-year earnings per share from continuing operations eased, while management issued 2026 guidance that points to higher expected revenue and GAAP EPS. We’ll now examine...